VR 478Alternative Names: VR478
Latest Information Update: 01 Nov 2005
At a glance
- Originator Vectura
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 01 Nov 2005 Discontinued - Preclinical for Epilepsy in United Kingdom (PO)
- 28 May 2003 Preclinical trials in Epilepsy in United Kingdom (PO)